aluates Reports

$ 0.0

Automative

Gastrointestinal Therapeutics and Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: September 2024

Report Code: QYRE-Auto-14S13291

Global Gastrointestinal Therapeutics and Diagnostics Market Research Report 2023

BUY CHAPTERS

Gastrointestinal Therapeutics and Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-14S13291

Report

September 2024

Pages:85

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Salix Pharmaceuticals

Takeda Pharmaceutical Company

Gastrointestinal Therapeutics and Diagnostics - Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Gastrointestinal Therapeutics and Diagnostics - Market

Gastrointestinal disorders are related to digestive system and generally affect the colon, small & large intestine and rectum. The disorders include constipation, peptic ulcer diseases and irritable bowel syndrome. The major reason and cause of GI disorders are stress, intake of medicines such as iron pills and anti-depressants and unhealthy eating habits. Symptoms of the gastrointestinal infections include pain, bloating, diarrhea, nausea and vomiting. The major drugs that dominate the gastrointestinal diagnostics and therapeutics market are aciphex, afinitor, akynzeo, dificid and Prilosec.

The global market for Gastrointestinal Therapeutics and Diagnostics was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Gastrointestinal Therapeutics and Diagnostics, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Gastrointestinal Therapeutics and Diagnostics by region & country, by Type, and by Application.

The Gastrointestinal Therapeutics and Diagnostics market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gastrointestinal Therapeutics and Diagnostics.

Market Segmentation

Scope of Gastrointestinal Therapeutics and Diagnostics - Market Report

Report Metric	Details
Report Name	Gastrointestinal Therapeutics and Diagnostics - Market
CAGR	5%
Segment by Type:	Diagnostics Therapeutics
Segment by Application	Gastroenteritis GI Bleeding Irritable Bowel Syndrome Peptic Ulcer Disease (PUD) Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Abbott Laboratories, AstraZeneca, Eisai, Johnson & Johnson, Salix Pharmaceuticals, Takeda Pharmaceutical Company
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Gastrointestinal Therapeutics and Diagnostics manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Gastrointestinal Therapeutics and Diagnostics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Gastrointestinal Therapeutics and Diagnostics in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Gastrointestinal Therapeutics and Diagnostics - Market report?

Ans: The main players in the Gastrointestinal Therapeutics and Diagnostics - Market are Abbott Laboratories, AstraZeneca, Eisai, Johnson & Johnson, Salix Pharmaceuticals, Takeda Pharmaceutical Company

What are the Application segmentation covered in the Gastrointestinal Therapeutics and Diagnostics - Market report?

Ans: The Applications covered in the Gastrointestinal Therapeutics and Diagnostics - Market report are Gastroenteritis, GI Bleeding, Irritable Bowel Syndrome, Peptic Ulcer Disease (PUD), Others

What are the Type segmentation covered in the Gastrointestinal Therapeutics and Diagnostics - Market report?

Ans: The Types covered in the Gastrointestinal Therapeutics and Diagnostics - Market report are Diagnostics, Therapeutics

1 Market Overview

1.1 Gastrointestinal Therapeutics and Diagnostics Product Introduction

1.2 Global Gastrointestinal Therapeutics and Diagnostics Market Size Forecast

1.3 Gastrointestinal Therapeutics and Diagnostics Market Trends & Drivers

1.3.1 Gastrointestinal Therapeutics and Diagnostics Industry Trends

1.3.2 Gastrointestinal Therapeutics and Diagnostics Market Drivers & Opportunity

1.3.3 Gastrointestinal Therapeutics and Diagnostics Market Challenges

1.3.4 Gastrointestinal Therapeutics and Diagnostics Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Gastrointestinal Therapeutics and Diagnostics Players Revenue Ranking (2023)

2.2 Global Gastrointestinal Therapeutics and Diagnostics Revenue by Company (2019-2024)

2.3 Key Companies Gastrointestinal Therapeutics and Diagnostics Manufacturing Base Distribution and Headquarters

2.4 Key Companies Gastrointestinal Therapeutics and Diagnostics Product Offered

2.5 Key Companies Time to Begin Mass Production of Gastrointestinal Therapeutics and Diagnostics

2.6 Gastrointestinal Therapeutics and Diagnostics Market Competitive Analysis

2.6.1 Gastrointestinal Therapeutics and Diagnostics Market Concentration Rate (2019-2024)

2.6.2 Global 5 and 10 Largest Companies by Gastrointestinal Therapeutics and Diagnostics Revenue in 2023

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Therapeutics and Diagnostics as of 2023)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Diagnostics

3.1.2 Therapeutics

3.2 Global Gastrointestinal Therapeutics and Diagnostics Sales Value by Type

3.2.1 Global Gastrointestinal Therapeutics and Diagnostics Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Gastrointestinal Therapeutics and Diagnostics Sales Value, by Type (2019-2030)

3.2.3 Global Gastrointestinal Therapeutics and Diagnostics Sales Value, by Type (%) (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Gastroenteritis

4.1.2 GI Bleeding

4.1.3 Irritable Bowel Syndrome

4.1.4 Peptic Ulcer Disease (PUD)

4.1.5 Others

4.2 Global Gastrointestinal Therapeutics and Diagnostics Sales Value by Application

4.2.1 Global Gastrointestinal Therapeutics and Diagnostics Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Gastrointestinal Therapeutics and Diagnostics Sales Value, by Application (2019-2030)

4.2.3 Global Gastrointestinal Therapeutics and Diagnostics Sales Value, by Application (%) (2019-2030)

5 Segmentation by Region

5.1 Global Gastrointestinal Therapeutics and Diagnostics Sales Value by Region

5.1.1 Global Gastrointestinal Therapeutics and Diagnostics Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Gastrointestinal Therapeutics and Diagnostics Sales Value by Region (2019-2024)

5.1.3 Global Gastrointestinal Therapeutics and Diagnostics Sales Value by Region (2025-2030)

5.1.4 Global Gastrointestinal Therapeutics and Diagnostics Sales Value by Region (%), (2019-2030)

5.2 North America

5.2.1 North America Gastrointestinal Therapeutics and Diagnostics Sales Value, 2019-2030

5.2.2 North America Gastrointestinal Therapeutics and Diagnostics Sales Value by Country (%), 2023 VS 2030

5.3 Europe

5.3.1 Europe Gastrointestinal Therapeutics and Diagnostics Sales Value, 2019-2030

5.3.2 Europe Gastrointestinal Therapeutics and Diagnostics Sales Value by Country (%), 2023 VS 2030

5.4 Asia Pacific

5.4.1 Asia Pacific Gastrointestinal Therapeutics and Diagnostics Sales Value, 2019-2030

5.4.2 Asia Pacific Gastrointestinal Therapeutics and Diagnostics Sales Value by Country (%), 2023 VS 2030

5.5 South America

5.5.1 South America Gastrointestinal Therapeutics and Diagnostics Sales Value, 2019-2030

5.5.2 South America Gastrointestinal Therapeutics and Diagnostics Sales Value by Country (%), 2023 VS 2030

5.6 Middle East & Africa

5.6.1 Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Sales Value, 2019-2030

5.6.2 Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Gastrointestinal Therapeutics and Diagnostics Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Gastrointestinal Therapeutics and Diagnostics Sales Value

6.3 United States

6.3.1 United States Gastrointestinal Therapeutics and Diagnostics Sales Value, 2019-2030

6.3.2 United States Gastrointestinal Therapeutics and Diagnostics Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Gastrointestinal Therapeutics and Diagnostics Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Gastrointestinal Therapeutics and Diagnostics Sales Value, 2019-2030

6.4.2 Europe Gastrointestinal Therapeutics and Diagnostics Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Gastrointestinal Therapeutics and Diagnostics Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Gastrointestinal Therapeutics and Diagnostics Sales Value, 2019-2030

6.5.2 China Gastrointestinal Therapeutics and Diagnostics Sales Value by Type (%), 2023 VS 2030

6.5.3 China Gastrointestinal Therapeutics and Diagnostics Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Gastrointestinal Therapeutics and Diagnostics Sales Value, 2019-2030

6.6.2 Japan Gastrointestinal Therapeutics and Diagnostics Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Gastrointestinal Therapeutics and Diagnostics Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Gastrointestinal Therapeutics and Diagnostics Sales Value, 2019-2030

6.7.2 South Korea Gastrointestinal Therapeutics and Diagnostics Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Gastrointestinal Therapeutics and Diagnostics Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Gastrointestinal Therapeutics and Diagnostics Sales Value, 2019-2030

6.8.2 Southeast Asia Gastrointestinal Therapeutics and Diagnostics Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Gastrointestinal Therapeutics and Diagnostics Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Gastrointestinal Therapeutics and Diagnostics Sales Value, 2019-2030

6.9.2 India Gastrointestinal Therapeutics and Diagnostics Sales Value by Type (%), 2023 VS 2030

6.9.3 India Gastrointestinal Therapeutics and Diagnostics Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Abbott Laboratories

7.1.1 Abbott Laboratories Profile

7.1.2 Abbott Laboratories Main Business

7.1.3 Abbott Laboratories Gastrointestinal Therapeutics and Diagnostics Products, Services and Solutions

7.1.4 Abbott Laboratories Gastrointestinal Therapeutics and Diagnostics Revenue (US$ Million) & (2019-2024)

7.1.5 Abbott Laboratories Recent Developments

7.2 AstraZeneca

7.2.1 AstraZeneca Profile

7.2.2 AstraZeneca Main Business

7.2.3 AstraZeneca Gastrointestinal Therapeutics and Diagnostics Products, Services and Solutions

7.2.4 AstraZeneca Gastrointestinal Therapeutics and Diagnostics Revenue (US$ Million) & (2019-2024)

7.2.5 AstraZeneca Recent Developments

7.3 Eisai

7.3.1 Eisai Profile

7.3.2 Eisai Main Business

7.3.3 Eisai Gastrointestinal Therapeutics and Diagnostics Products, Services and Solutions

7.3.4 Eisai Gastrointestinal Therapeutics and Diagnostics Revenue (US$ Million) & (2019-2024)

7.3.5 Johnson & Johnson Recent Developments

7.4 Johnson & Johnson

7.4.1 Johnson & Johnson Profile

7.4.2 Johnson & Johnson Main Business

7.4.3 Johnson & Johnson Gastrointestinal Therapeutics and Diagnostics Products, Services and Solutions

7.4.4 Johnson & Johnson Gastrointestinal Therapeutics and Diagnostics Revenue (US$ Million) & (2019-2024)

7.4.5 Johnson & Johnson Recent Developments

7.5 Salix Pharmaceuticals

7.5.1 Salix Pharmaceuticals Profile

7.5.2 Salix Pharmaceuticals Main Business

7.5.3 Salix Pharmaceuticals Gastrointestinal Therapeutics and Diagnostics Products, Services and Solutions

7.5.4 Salix Pharmaceuticals Gastrointestinal Therapeutics and Diagnostics Revenue (US$ Million) & (2019-2024)

7.5.5 Salix Pharmaceuticals Recent Developments

7.6 Takeda Pharmaceutical Company

7.6.1 Takeda Pharmaceutical Company Profile

7.6.2 Takeda Pharmaceutical Company Main Business

7.6.3 Takeda Pharmaceutical Company Gastrointestinal Therapeutics and Diagnostics Products, Services and Solutions

7.6.4 Takeda Pharmaceutical Company Gastrointestinal Therapeutics and Diagnostics Revenue (US$ Million) & (2019-2024)

7.6.5 Takeda Pharmaceutical Company Recent Developments

8 Industry Chain Analysis

8.1 Gastrointestinal Therapeutics and Diagnostics Industrial Chain

8.2 Gastrointestinal Therapeutics and Diagnostics Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Gastrointestinal Therapeutics and Diagnostics Sales Model

8.5.2 Sales Channel

8.5.3 Gastrointestinal Therapeutics and Diagnostics Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Salix Pharmaceuticals

Takeda Pharmaceutical Company

List of Tables

Table 1. Gastrointestinal Therapeutics and Diagnostics Market Trends

Table 2. Gastrointestinal Therapeutics and Diagnostics Market Drivers & Opportunity

Table 3. Gastrointestinal Therapeutics and Diagnostics Market Challenges

Table 4. Gastrointestinal Therapeutics and Diagnostics Market Restraints

Table 5. Global Gastrointestinal Therapeutics and Diagnostics Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Company (2019-2024)

Table 7. Key Companies Gastrointestinal Therapeutics and Diagnostics Manufacturing Base Distribution and Headquarters

Table 8. Key Companies Gastrointestinal Therapeutics and Diagnostics Product Type

Table 9. Key Companies Time to Begin Mass Production of Gastrointestinal Therapeutics and Diagnostics

Table 10. Global Gastrointestinal Therapeutics and Diagnostics Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Therapeutics and Diagnostics as of 2023)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global Gastrointestinal Therapeutics and Diagnostics Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 14. Global Gastrointestinal Therapeutics and Diagnostics Sales Value by Type (2019-2024) & (US$ Million)

Table 15. Global Gastrointestinal Therapeutics and Diagnostics Sales Value by Type (2025-2030) & (US$ Million)

Table 16. Global Gastrointestinal Therapeutics and Diagnostics Sales Market Share in Value by Type (2019-2024) & (%)

Table 17. Global Gastrointestinal Therapeutics and Diagnostics Sales Market Share in Value by Type (2025-2030) & (%)

Table 18. Global Gastrointestinal Therapeutics and Diagnostics Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 19. Global Gastrointestinal Therapeutics and Diagnostics Sales Value by Application (2019-2024) & (US$ Million)

Table 20. Global Gastrointestinal Therapeutics and Diagnostics Sales Value by Application (2025-2030) & (US$ Million)

Table 21. Global Gastrointestinal Therapeutics and Diagnostics Sales Market Share in Value by Application (2019-2024) & (%)

Table 22. Global Gastrointestinal Therapeutics and Diagnostics Sales Market Share in Value by Application (2025-2030) & (%)

Table 23. Global Gastrointestinal Therapeutics and Diagnostics Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 24. Global Gastrointestinal Therapeutics and Diagnostics Sales Value by Region (2019-2024) & (US$ Million)

Table 25. Global Gastrointestinal Therapeutics and Diagnostics Sales Value by Region (2025-2030) & (US$ Million)

Table 26. Global Gastrointestinal Therapeutics and Diagnostics Sales Value by Region (2019-2024) & (%)

Table 27. Global Gastrointestinal Therapeutics and Diagnostics Sales Value by Region (2025-2030) & (%)

Table 28. Key Countries/Regions Gastrointestinal Therapeutics and Diagnostics Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 29. Key Countries/Regions Gastrointestinal Therapeutics and Diagnostics Sales Value, (2019-2024) & (US$ Million)

Table 30. Key Countries/Regions Gastrointestinal Therapeutics and Diagnostics Sales Value, (2025-2030) & (US$ Million)

Table 31. Abbott Laboratories Basic Information List

Table 32. Abbott Laboratories Description and Business Overview

Table 33. Abbott Laboratories Gastrointestinal Therapeutics and Diagnostics Products, Services and Solutions

Table 34. Revenue (US$ Million) in Gastrointestinal Therapeutics and Diagnostics Business of Abbott Laboratories (2019-2024)

Table 35. Abbott Laboratories Recent Developments

Table 36. AstraZeneca Basic Information List

Table 37. AstraZeneca Description and Business Overview

Table 38. AstraZeneca Gastrointestinal Therapeutics and Diagnostics Products, Services and Solutions

Table 39. Revenue (US$ Million) in Gastrointestinal Therapeutics and Diagnostics Business of AstraZeneca (2019-2024)

Table 40. AstraZeneca Recent Developments

Table 41. Eisai Basic Information List

Table 42. Eisai Description and Business Overview

Table 43. Eisai Gastrointestinal Therapeutics and Diagnostics Products, Services and Solutions

Table 44. Revenue (US$ Million) in Gastrointestinal Therapeutics and Diagnostics Business of Eisai (2019-2024)

Table 45. Eisai Recent Developments

Table 46. Johnson & Johnson Basic Information List

Table 47. Johnson & Johnson Description and Business Overview

Table 48. Johnson & Johnson Gastrointestinal Therapeutics and Diagnostics Products, Services and Solutions

Table 49. Revenue (US$ Million) in Gastrointestinal Therapeutics and Diagnostics Business of Johnson & Johnson (2019-2024)

Table 50. Johnson & Johnson Recent Developments

Table 51. Salix Pharmaceuticals Basic Information List

Table 52. Salix Pharmaceuticals Description and Business Overview

Table 53. Salix Pharmaceuticals Gastrointestinal Therapeutics and Diagnostics Products, Services and Solutions

Table 54. Revenue (US$ Million) in Gastrointestinal Therapeutics and Diagnostics Business of Salix Pharmaceuticals (2019-2024)

Table 55. Salix Pharmaceuticals Recent Developments

Table 56. Takeda Pharmaceutical Company Basic Information List

Table 57. Takeda Pharmaceutical Company Description and Business Overview

Table 58. Takeda Pharmaceutical Company Gastrointestinal Therapeutics and Diagnostics Products, Services and Solutions

Table 59. Revenue (US$ Million) in Gastrointestinal Therapeutics and Diagnostics Business of Takeda Pharmaceutical Company (2019-2024)

Table 60. Takeda Pharmaceutical Company Recent Developments

Table 61. Key Raw Materials Lists

Table 62. Raw Materials Key Suppliers Lists

Table 63. Gastrointestinal Therapeutics and Diagnostics Downstream Customers

Table 64. Gastrointestinal Therapeutics and Diagnostics Distributors List

Table 65. Research Programs/Design for This Report

Table 66. Key Data Information from Secondary Sources

Table 67. Key Data Information from Primary Sources

Table 68. Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Gastrointestinal Therapeutics and Diagnostics Product Picture

Figure 2. Global Gastrointestinal Therapeutics and Diagnostics Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Gastrointestinal Therapeutics and Diagnostics Sales Value (2019-2030) & (US$ Million)

Figure 4. Gastrointestinal Therapeutics and Diagnostics Report Years Considered

Figure 5. Global Gastrointestinal Therapeutics and Diagnostics Players Revenue Ranking (2023) & (US$ Million)

Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Gastrointestinal Therapeutics and Diagnostics Revenue in 2023

Figure 7. Gastrointestinal Therapeutics and Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 8. Diagnostics Picture

Figure 9. Therapeutics Picture

Figure 10. Global Gastrointestinal Therapeutics and Diagnostics Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 11. Global Gastrointestinal Therapeutics and Diagnostics Sales Value Market Share by Type, 2023 & 2030

Figure 12. Product Picture of Gastroenteritis

Figure 13. Product Picture of GI Bleeding

Figure 14. Product Picture of Irritable Bowel Syndrome

Figure 15. Product Picture of Peptic Ulcer Disease (PUD)

Figure 16. Product Picture of Others

Figure 17. Global Gastrointestinal Therapeutics and Diagnostics Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 18. Global Gastrointestinal Therapeutics and Diagnostics Sales Value Market Share by Application, 2023 & 2030

Figure 19. North America Gastrointestinal Therapeutics and Diagnostics Sales Value (2019-2030) & (US$ Million)

Figure 20. North America Gastrointestinal Therapeutics and Diagnostics Sales Value by Country (%), 2023 VS 2030

Figure 21. Europe Gastrointestinal Therapeutics and Diagnostics Sales Value (2019-2030) & (US$ Million)

Figure 22. Europe Gastrointestinal Therapeutics and Diagnostics Sales Value by Country (%), 2023 VS 2030

Figure 23. Asia Pacific Gastrointestinal Therapeutics and Diagnostics Sales Value (2019-2030) & (US$ Million)

Figure 24. Asia Pacific Gastrointestinal Therapeutics and Diagnostics Sales Value by Country (%), 2023 VS 2030

Figure 25. South America Gastrointestinal Therapeutics and Diagnostics Sales Value (2019-2030) & (US$ Million)

Figure 26. South America Gastrointestinal Therapeutics and Diagnostics Sales Value by Country (%), 2023 VS 2030

Figure 27. Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Sales Value (2019-2030) & (US$ Million)

Figure 28. Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Sales Value by Country (%), 2023 VS 2030

Figure 29. Key Countries/Regions Gastrointestinal Therapeutics and Diagnostics Sales Value (%), (2019-2030)

Figure 30. United States Gastrointestinal Therapeutics and Diagnostics Sales Value, (2019-2030) & (US$ Million)

Figure 31. United States Gastrointestinal Therapeutics and Diagnostics Sales Value by Type (%), 2023 VS 2030

Figure 32. United States Gastrointestinal Therapeutics and Diagnostics Sales Value by Application (%), 2023 VS 2030

Figure 33. Europe Gastrointestinal Therapeutics and Diagnostics Sales Value, (2019-2030) & (US$ Million)

Figure 34. Europe Gastrointestinal Therapeutics and Diagnostics Sales Value by Type (%), 2023 VS 2030

Figure 35. Europe Gastrointestinal Therapeutics and Diagnostics Sales Value by Application (%), 2023 VS 2030

Figure 36. China Gastrointestinal Therapeutics and Diagnostics Sales Value, (2019-2030) & (US$ Million)

Figure 37. China Gastrointestinal Therapeutics and Diagnostics Sales Value by Type (%), 2023 VS 2030

Figure 38. China Gastrointestinal Therapeutics and Diagnostics Sales Value by Application (%), 2023 VS 2030

Figure 39. Japan Gastrointestinal Therapeutics and Diagnostics Sales Value, (2019-2030) & (US$ Million)

Figure 40. Japan Gastrointestinal Therapeutics and Diagnostics Sales Value by Type (%), 2023 VS 2030

Figure 41. Japan Gastrointestinal Therapeutics and Diagnostics Sales Value by Application (%), 2023 VS 2030

Figure 42. South Korea Gastrointestinal Therapeutics and Diagnostics Sales Value, (2019-2030) & (US$ Million)

Figure 43. South Korea Gastrointestinal Therapeutics and Diagnostics Sales Value by Type (%), 2023 VS 2030

Figure 44. South Korea Gastrointestinal Therapeutics and Diagnostics Sales Value by Application (%), 2023 VS 2030

Figure 45. Southeast Asia Gastrointestinal Therapeutics and Diagnostics Sales Value, (2019-2030) & (US$ Million)

Figure 46. Southeast Asia Gastrointestinal Therapeutics and Diagnostics Sales Value by Type (%), 2023 VS 2030

Figure 47. Southeast Asia Gastrointestinal Therapeutics and Diagnostics Sales Value by Application (%), 2023 VS 2030

Figure 48. India Gastrointestinal Therapeutics and Diagnostics Sales Value, (2019-2030) & (US$ Million)

Figure 49. India Gastrointestinal Therapeutics and Diagnostics Sales Value by Type (%), 2023 VS 2030

Figure 50. India Gastrointestinal Therapeutics and Diagnostics Sales Value by Application (%), 2023 VS 2030

Figure 51. Gastrointestinal Therapeutics and Diagnostics Industrial Chain

Figure 52. Gastrointestinal Therapeutics and Diagnostics Manufacturing Cost Structure

Figure 53. Channels of Distribution (Direct Sales, and Distribution)

Figure 54. Bottom-up and Top-down Approaches for This Report

Figure 55. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Clotting Factors Ⅷ Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-21S8513

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Rare Genetic Disease Diagnosis Solution - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-17L15214

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Endoscopes for Otology - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-19V14797

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Immunotherapy Drugs for Neuroblastoma - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-39R14639

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions